INDUSTRY NEWS
Venture Funding Stabilizes, Shifts to Biotech, Shuns Energy Venture-capital funding for startup companies stabilized in the fourth quarter, with investor interest shifting toward drug development and away from clean energy. [Bloomberg Press Release]
Neuralstem Announces First Patient Treated in Amyotrophic Lateral Sclerosis Stem Cell Trial Neuralstem, Inc. announced that the first amyotrophic lateral sclerosis (ALS) patient was treated with its spinal cord stem cells at the Emory ALS Center at Emory University, in Atlanta, Georgia. [Neuralstem, Inc. Press Release]
Living Cell Technologies Granted European Patent for Neurological Disease Product NTCELL Living Cell Technologies announced that it has been granted a European patent for the use of its product NTCELL in the treatment of degenerative neurological conditions such as Parkinson’s disease, Alzheimer’s disease, Multiple Sclerosis , Huntington’s disease and Stroke. [Living Cell Technologies Limited Press Release]
Neurologix Gains Broadened U.S. Patent Protection for Its GAD-Based Gene Delivery System Neurologix, Inc. announced that the U.S. Patent and Trademark Office has expanded the intellectual property protections enabled by a previously issued patent that is central to Neurologix’s Parkinson’s disease program. [Neurologix, Inc. Press Release]
The Automation Partnership Begins New Five Year Collaboration with Top Regenerative Medicine Centre Following an Injection of £5.3 Million from the United Kingdom Government The Automation Partnership announced recently that its collaboration with leading translational research group, the Engineering and Physical Sciences Research Council Centre for Innovative Manufacturing in Regenerative Medicine at Loughborough University is to continue into a second five year phase. [The Automation Partnership Press Release]
Scientific Breakthrough: Baltimore’s Bioparks Enjoy a Growth Spurt Companies are taking more space in Baltimore’s two emerging biotechnology research centers; at least one firm is mulling a venture capital-backed funding round; and plans to expand the University of Maryland, Baltimore’s biopark are still on the table. [Baltimore Business Journal]
|
|
POLICY NEWS
In Tough Economic Times, National Institutes of Health Head Looks to Clinic As he puts together his budget proposal for the coming year, National Institutes of Health director Dr. Francis Collins plans to do something a little different – emphasizing the “health” in the name of his U.S. agency. [National Institutes of Health, United States]
Maryland Stem Cell Commission Gets 141 Applications for Grants The Maryland Stem Cell Research Commission has received 141 applications for $45 million in research grants, but only $12 million is available. [The Maryland Stem Cell Research Commission, United States]
National Institutes of Health Recommends Approval of Another Stem Cell Line A National Institutes of Health advisory committee voted to recommend the first human embryonic stem cell line leftover from Bush administration to receive federal research funding. [National Institutes of Health, United States]
Clarification on the Extended Error Correction Window and Format of the Research Strategy Section for Restructured Applications Intended for Due Dates on or After January 25, 2010 (NOT-OD-10-050) [National Institutes of Health, United States]
FY2010 Recovery Act Funding Announcements: Clarification on Page Limitations for Bibliography and References Cited Section (NOT-OD-10-051) [National Institutes of Health, United States]
Clarification of SF424 (R&R) Application Instructions for Resubmissions of Revision and Renewal Applications (NOT-OD-10-052) [National Institutes of Health, United States]
|
|
EVENTS
CHI’s Molecular Medicine Tri-Conference 2010 February 3-5, 2010 San Francisco, United States
Keystone Symposia: Stem Cell Differentiation and Dedifferentiation (B4) February 15-20, 2010 Keystone, United States
17th Annual Conference of the American Society for Neural Therapy & Repair April 29-May 1, 2010 Clearwater Beach, United States
2010 Canadian Neuroscience Meeting May 15-18, 2010 Ottawa, Canada
ISSCR 8th Annual Meeting June 16-19, 2010 San Francisco, United States 7th Forum of European Neuroscience July 3-7, 2010 Amsterdam, The Netherlands
40th Annual Neuroscience 2010 November 13-17, 2010 San Diego, United States
JOB OPPORTUNITIES
Business Development Europe – Cell Therapy Products (PALL Corporation)
Research & Development Scientist – Pancreatic Cell Biology (STEMCELL Technologies)
Research & Development Scientist – Endothelial Cell Biology (STEMCELL Technologies)
Research & Development Scientist – Epithelial Cell Biology (STEMCELL Technologies)
Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News.
Visit here to post your career opportunities.
|
| |